Adaptimmune Therapeutics Plc Bennfentes tulajdonlás
Mi az Adaptimmune Therapeutics Plc Bennfentes tulajdonlás?
A Bennfentes tulajdonlás az Adaptimmune Therapeutics Plc - 0.17%
Mi a Bennfentes tulajdonlás meghatározása?
A bennfentes tulajdonjog kiszámítása a bennfentesek tulajdonában lévő részvények (részvényesek, akik a vállalat több mint 5% -át, vagy a vállalat tisztségviselőjét vagy igazgatóját birtokolják) teljes létszámával, osztva a teljes részvénykivonással.
A high value of insider ownership means that those working for the company have a large stake in the success of the company. This is sometimes seen as a sign that those running the company will work hard to ensure its success or believe the company's stock price will rise.
A change in insider ownership may come from exercise of option, stock grant and buying or selling of company shares. A purchase of company share signifies a confidence in the company's future performance by people who know the company best. Therefore, Net Insider buying is also an important indicator for investors.
Bennfentes tulajdonlás a Health Care szektor a NASDAQ-on cégekben a Adaptimmune Therapeutics Plc -hoz képest
Mit csinál Adaptimmune Therapeutics Plc?
adaptimmune llc is a multinational, clinical-stage biopharmaceutical company focused on developing novel immunotherapies using its proprietary t-cell receptor platform that has the potential to transform the treatment of cancer. established in 2008, the company has grown from being privately held to one of the most successful biopharmaceutical initial public offerings (ipo) in 2015. with u.s. operations based in philadelphia, pa, adaptimmune is a company founded on strong science that has led to a robust pipeline of immuno-oncology product candidates, a growing research & development platform and ongoing plans for expansion. for more information about adaptimmune, please visit www.adaptimmune.com. if interested in joining our fast growing team, click on the careers tab of this page.
bennfentes tulajdonlás -hoz hasonló cégek Adaptimmune Therapeutics Plc
- Aberdeen Asia-Pacific Income Investment Co nak Bennfentes tulajdonlás 0.17% van
- Element Fleet Management nak Bennfentes tulajdonlás 0.17% van
- McDonald`s Corp nak Bennfentes tulajdonlás 0.17% van
- Domtar nak Bennfentes tulajdonlás 0.17% van
- HP nak Bennfentes tulajdonlás 0.17% van
- Shopify nak Bennfentes tulajdonlás 0.17% van
- Adaptimmune Therapeutics Plc nak Bennfentes tulajdonlás 0.17% van
- Bank Of New York Mellon Corp nak Bennfentes tulajdonlás 0.17% van
- Swiss Prime Site AG nak Bennfentes tulajdonlás 0.17% van
- Occidental Petroleum nak Bennfentes tulajdonlás 0.17% van
- Deere & Co nak Bennfentes tulajdonlás 0.17% van
- The Bank of New York Mellon nak Bennfentes tulajdonlás 0.17% van
- Waste Management nak Bennfentes tulajdonlás 0.17% van